Festival of Genomics – Special Invitation Event “Enabling and Emerging Technologies in Drug Development”
24 January, 1:00-5.00pm.
Future Genetics are actively participating in this years Festival of Genomics. In addition to the speaker event and the Live Lounge sessions on the 23 January, Dr Kamran has been asked to attend an invitation-only special interest session on 24 January for Round-table and interaction discussion. The pharma SIG this year is on Enabling and Emerging Technologies in Drug Development. Making the scientific priorities match up with the commercial reality of working in industry isn’t always straight forward – so this will look at the drug development processes and address where the opportunities are to increase translational success, clinical success, and how to improve internal processes and assets. Where specific technologies could have a potential positive impact, those will be assessed in more detail to understand how realistic that potential is and what successful integration would look like. The session is broad stakeholder representation including:
Aroon Hingorani, Leader of Genetic Epidemiology Group, UCL
John Overington, Chief Information Officer, Catapult Medicines Discovery
Nicola Beer, Senior Head of Department, Novo Nordisk
Victor Neduva, Group Leader, GSK
Jon Moore, Chief Scientific Officer, Horizon Discovery
Joshua Kaggie, Research Associate, Department of Radiology, University of Cambridge
Philippe Sanseau, Head of the Global Computational Biology and Stats Department, GSK
Alun McCarthy, Vice President, Novel Target Biology & Genomics, C4X Discovery
Miika Ahdesmäki, Director of Bioinformatics, Cambridge Epigenetix
Satu Nahkuri, Principal Data Scientist, Roche
Charles Paulding, Director Pharmacogenomics, Regeneron
Eddie Blair, Respiratory Disease Biomarker Lead, UCB & Managing Director, Integrated Medicines
Krzysztof Potempa, CEO and Founder of BRAINCURES
The festival of genomics has been organised by front line genomics and they have created this fantastic conference that addresses key issues in the field. It is one of the biggest genomics events in Europe where 2000 attendees are expected based on previous attendances, there will be over 50 exhibitors including companies such as Illumina. There is an impressive list of speakers that represent stakeholders across industry, healthcare, and the research setting. The event organisers have stated that the event is made up of the best speaker line-up yet. As well as Dr Kamran there are other speakers including James O’Shaughnessy who is the minister for the department of health and social care, Dame Fiona Caldicott who heads up the governments national data guardian, and Dr Sue Hill from NHS England.
In addition to this several our Future Genetics researchers will be attending the event, including myself. I look forward to meeting friends and meeting new people who are just as passionate about making a difference as me.